BRPI0512660A - tablete carregável, e, método para a preparação de um tablete - Google Patents

tablete carregável, e, método para a preparação de um tablete

Info

Publication number
BRPI0512660A
BRPI0512660A BRPI0512660-6A BRPI0512660A BRPI0512660A BR PI0512660 A BRPI0512660 A BR PI0512660A BR PI0512660 A BRPI0512660 A BR PI0512660A BR PI0512660 A BRPI0512660 A BR PI0512660A
Authority
BR
Brazil
Prior art keywords
tablet
loaded
preparing
loadable
batch
Prior art date
Application number
BRPI0512660-6A
Other languages
English (en)
Inventor
Per Holm
Jannie Egeskov Holm
Thomas Ruhland
Simon Dalsgaard Nielsen
Original Assignee
Lifecycle Pharma As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lifecycle Pharma As filed Critical Lifecycle Pharma As
Publication of BRPI0512660A publication Critical patent/BRPI0512660A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/366—Lactones having six-membered rings, e.g. delta-lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/436—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having oxygen as a ring hetero atom, e.g. rapamycin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

TABLETE CARREGáVEL, E, MéTODO PARA A PREPARAçãO DE UM TABLETE Um produto novo de tablete, que de uma forma fácil, flexível e reproduzível, pode ser carregado com uma quantidade relativamente elevada de uma formulação líquida aceitável farmaceuticamente, como por exemplo, transportando uma substância terapeuticamente, profilática- mente e/ou diagnosticamente ativa. O produto de tablete novo carregado poderá ser produzido em bateladas em larga escala e ser estocado até ser utilizado, e cada batelada ou sub-batelada poderá ser carregada com as mesmas ou diferentes formulações e/ou substâncias ativas líquidas farmaceuticamente aceitáveis. Um tablete carregado de acordo com a invenção tem uma porosidade de 30% p/p, ou maior. A invenção também apresenta tabletes que foram carregados com uma formulação líquida, assim como um método para a preparação dos mesmos.
BRPI0512660-6A 2004-06-28 2005-06-27 tablete carregável, e, método para a preparação de um tablete BRPI0512660A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA200401011 2004-06-28
PCT/DK2005/000436 WO2006000229A2 (en) 2004-06-28 2005-06-27 Porous tablets as carriers for liquid formulations

Publications (1)

Publication Number Publication Date
BRPI0512660A true BRPI0512660A (pt) 2008-04-01

Family

ID=34973932

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0512660-6A BRPI0512660A (pt) 2004-06-28 2005-06-27 tablete carregável, e, método para a preparação de um tablete

Country Status (11)

Country Link
US (2) US20090181083A1 (pt)
EP (1) EP1765297A2 (pt)
JP (1) JP5403912B2 (pt)
KR (1) KR101352299B1 (pt)
CN (2) CN1976751A (pt)
AU (1) AU2005256322C1 (pt)
BR (1) BRPI0512660A (pt)
CA (1) CA2572180C (pt)
EA (1) EA013632B1 (pt)
MX (1) MXPA06014894A (pt)
WO (1) WO2006000229A2 (pt)

Families Citing this family (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8980894B2 (en) 2004-03-25 2015-03-17 Boehringer Ingelheim Vetmedica Gmbh Use of PDE III inhibitors for the treatment of asymptomatic (occult) heart failure
EP1579862A1 (en) 2004-03-25 2005-09-28 Boehringer Ingelheim Vetmedica Gmbh Use of PDE III inhibitors for the reduction of heart size in mammals suffering from heart failure
US8168206B1 (en) 2005-10-06 2012-05-01 Allergan, Inc. Animal protein-free pharmaceutical compositions
US8137677B2 (en) * 2005-10-06 2012-03-20 Allergan, Inc. Non-protein stabilized clostridial toxin pharmaceutical compositions
AU2007203715B2 (en) * 2006-01-05 2012-08-02 Veloxis Pharmaceuticals A/S Disintegrating loadable tablets
SI22237A (sl) * 2006-04-06 2007-10-31 Igc Center D.O.O. Porozne tablete za naknadno polnjenje z zdravilnouäśinkovino
EP1920785A1 (en) 2006-11-07 2008-05-14 Boehringer Ingelheim Vetmedica Gmbh Liquid preparation comprising a complex of pimobendan and cyclodextrin
DE102006054638B4 (de) * 2006-11-16 2014-12-04 Laburnum Gmbh Pharmazeutische Einzeldosisform
MX2009008935A (es) 2007-02-23 2009-11-02 Gilead Sciences Inc Moduladores de las propiedades farmacocineticas de productos terapeuticos.
KR100883825B1 (ko) * 2007-04-18 2009-02-16 김남호 규소 조성물 및 이를 함유한 음용수 제조방법
GB0709541D0 (en) * 2007-05-17 2007-06-27 Jagotec Ag Pharmaceutical excipient
MX2010011963A (es) 2008-05-02 2010-12-06 Gilead Sciences Inc Uso de particulas trasportadoras solidas para mejorar la capacidad de procesamiento de un agente farmaceutico.
KR101751906B1 (ko) 2009-03-04 2017-06-29 엠플리큐어 아베 새로운 오용 방지 배합물
EP2427177B1 (en) 2009-05-08 2018-03-28 Emplicure AB Composition for sustained drug delivery comprising geopolymeric binder
CN101991513B (zh) * 2009-08-12 2013-06-12 陈励 用于个人护理的化妆品和药品的生产原料
US9370493B2 (en) 2009-10-23 2016-06-21 Pronova Biopharma Norge As Coated capsules and tablets of a fatty acid oil mixture
CN102038638B (zh) * 2009-10-26 2012-12-26 海口市制药厂有限公司 盐酸克林霉素注射液及其制备方法
WO2011154012A1 (en) 2010-06-10 2011-12-15 Lifecycle Pharma A/S Mini-tablets comprising porous adsorbent material
WO2011154009A1 (en) 2010-06-10 2011-12-15 Lifecycle Pharma A/S Composition comprising an active principle in an amorphous form and a porous adsorbent material
WO2011154013A1 (en) 2010-06-10 2011-12-15 Lifecycle Pharma A/S Pharmaceutical composition comprising fenofibric acid
CN101919822B (zh) * 2010-07-16 2013-10-23 钟术光 综合性能改善的片剂及其制备方法
NO2613784T3 (pt) 2010-09-07 2018-05-12
CN102018960A (zh) * 2010-12-01 2011-04-20 安徽省皖北药业股份有限公司 一种保持克林霉素磷酸酯注射液质量稳定性的方法
CN102382125B (zh) * 2011-07-29 2014-04-09 成都市考恩斯科技有限责任公司 头孢妥仑的水溶性复合物及其制备方法和相应药物制剂
HUE060093T2 (hu) 2012-03-15 2023-01-28 Boehringer Ingelheim Vetmedica Gmbh Gyógyszerészeti tablettakészítmény az állatgyógyászati ágazat számára, eljárás annak elõállítására és annak alkalmazása
WO2013150386A2 (en) 2012-04-04 2013-10-10 Pronova Biopharma Norge As Compositions comprising omega-3 fatty acids and vitamin d for acne vulgaris and/or eczema, and methods and uses thereof
US9585896B2 (en) 2012-04-04 2017-03-07 Pronova Biopharma Norge As Compositions comprising omega-3 fatty acids and vitamin D for psoriasis, and methods and uses thereof
HUE054186T2 (hu) 2013-07-19 2021-08-30 Boehringer Ingelheim Vetmedica Gmbh Éterezett ciklodextrin-származékokat tartalmazó, tartósított, folyékony, vizes gyógyászati készítmény
CN113413393B (zh) 2013-08-19 2025-03-04 塔里斯生物医药公司 多单元药物递送装置和方法
ES2883448T3 (es) 2013-12-04 2021-12-07 Boehringer Ingelheim Vetmedica Gmbh Composiciones farmacéuticas mejoradas de pimobendán
KR101556568B1 (ko) * 2013-12-17 2015-10-01 주식회사 대웅제약 콜린 알포세레이트를 함유하는 필름코팅정 및 이의 제조방법
ES2851332T3 (es) * 2014-06-19 2021-09-06 Solural Pharma ApS Forma sólida de dosificación oral de compuestos lipofílicos
CN104523592B (zh) * 2015-01-26 2017-03-15 湖北工业大学 甲泼尼龙醋酸酯注射用自微乳制剂及其制备方法
US10328087B2 (en) 2015-07-23 2019-06-25 Therapeuticsmd, Inc. Formulations for solubilizing hormones
WO2017173044A1 (en) * 2016-04-01 2017-10-05 Therapeuticsmd Inc. Steroid hormone compositions in medium chain oils
WO2017173071A1 (en) 2016-04-01 2017-10-05 Therapeuticsmd, Inc. Steroid hormone pharmaceutical composition
US10537570B2 (en) 2016-04-06 2020-01-21 Boehringer Ingelheim Vetmedica Gmbh Use of pimobendan for the reduction of heart size and/or the delay of onset of clinical symptoms in patients with asymptomatic heart failure due to mitral valve disease
KR102480965B1 (ko) 2016-09-13 2022-12-26 알레간 인코포레이티드 안정화된 비단백질 클로스트리듐 독소 조성물
JP2019007235A (ja) * 2017-06-26 2019-01-17 アイシン精機株式会社 洗浄便座装置
JP7285846B2 (ja) 2018-02-01 2023-06-02 ダウ グローバル テクノロジーズ エルエルシー 半結晶性ポリオレフィンキャリア樹脂を有するマスターバッチ
JP7303200B2 (ja) 2018-02-01 2023-07-04 ダウ グローバル テクノロジーズ エルエルシー 半結晶性ポリオレフィンキャリア樹脂を有するマスターバッチ
CN108517365B (zh) * 2018-03-27 2021-03-19 东北农业大学 一种提高猪天然免疫力的Sp100分子标记育种方法及其应用
AU2019294614A1 (en) * 2018-06-25 2021-02-11 Titan Pharmaceuticals, Inc. Loadable porous structures for use as implants
CN111067876B (zh) * 2019-12-04 2022-08-16 宁夏大学 一种α-亚麻酸双层片及其制备方法
CN110974919A (zh) * 2019-12-23 2020-04-10 湛江寸草制药有限公司 一种神阙穴肚脐给药的药物载体脐炭丸及其制备方法与应用
EP4129342B1 (en) * 2020-03-31 2025-10-15 Eisai R&D Management Co., Ltd. Tablet, medicine, and method and kit for manufacturing said tablet and medicine
CN111905836B (zh) * 2020-08-14 2024-08-13 上海组波智能仪器科技有限公司 一种多孔塑料化学试剂载体及其制备方法和应用
KR102366486B1 (ko) * 2021-06-15 2022-02-23 대한민국 천공성해충 피해방지제 조성물

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5444034A (en) * 1977-09-14 1979-04-07 Kanebo Ltd Easily absorbable nifedipine composition and anti- stenocardia containing said composition
EP0001247A1 (en) * 1977-09-14 1979-04-04 Kanebo, Ltd. Pharmaceutical preparation containing nifedipine and a method for producing the same.
TW222585B (pt) * 1992-09-11 1994-04-21 Hoechst Ag
JP2700141B2 (ja) * 1993-09-17 1998-01-19 富士化学工業株式会社 リン酸水素カルシウム及びその製法並びにそれを用いた賦形剤
KR100618234B1 (ko) * 1998-12-23 2006-09-01 알자 코포레이션 다공성 입자를 포함하는 제형
US6399591B1 (en) * 2000-01-19 2002-06-04 Yung-Shin Pharmaceutical Ind. Co., Ltd. Chargeable pharmaceutical tablets
CA2478101A1 (en) * 2002-03-06 2003-09-12 Kyowa Hakko Kogyo Co., Ltd. Intraorally rapidly disintegrable tablets
JP2008504123A (ja) * 2004-06-28 2008-02-14 ホー・ルンドベック・アクティーゼルスカブ 化学物質をデリバリーするための多孔質物品
AU2007203715B2 (en) * 2006-01-05 2012-08-02 Veloxis Pharmaceuticals A/S Disintegrating loadable tablets
US20110244031A1 (en) * 2010-03-31 2011-10-06 Lifecycle Pharma A/S Porous tablets as carriers for liquid formulations

Also Published As

Publication number Publication date
CN101001613A (zh) 2007-07-18
US20090181083A1 (en) 2009-07-16
CN101001613B (zh) 2010-09-29
JP2008504308A (ja) 2008-02-14
EP1765297A2 (en) 2007-03-28
KR20070035033A (ko) 2007-03-29
CN1976751A (zh) 2007-06-06
WO2006000229A2 (en) 2006-01-05
US20150164812A1 (en) 2015-06-18
AU2005256322B2 (en) 2011-03-03
MXPA06014894A (es) 2007-03-21
CA2572180C (en) 2014-05-20
KR101352299B1 (ko) 2014-02-17
WO2006000229A3 (en) 2006-08-24
JP5403912B2 (ja) 2014-01-29
AU2005256322A1 (en) 2006-01-05
EA200700173A1 (ru) 2007-04-27
CA2572180A1 (en) 2006-01-05
EA013632B1 (ru) 2010-06-30
AU2005256322C1 (en) 2011-07-07

Similar Documents

Publication Publication Date Title
BRPI0512660A (pt) tablete carregável, e, método para a preparação de um tablete
Fetherston et al. A silicone elastomer vaginal ring for HIV prevention containing two microbicides with different mechanisms of action
AR116035A2 (es) Formulación farmacéutica - 514
MX2023007117A (es) Formulacion liquida para preparar un vehiculo de suministro que comprende un polimero termosensible y un polimero sensible a iones.
ATE424848T1 (de) Pharmazeutische zusammensetzungen für die kontrollierte freigabe von biologischen wirkstoffen
CL2020001762A1 (es) Formas cristalinas del derivado de 4-pirimidinsulfamida de aprocitentán. (divisional solicitud 201902464)
BRPI0615860B8 (pt) composição farmacêutica de liberação prolongada monolítica sólida
WO2008089151A3 (en) High dose film compositions and methods of preparation
GT199900203A (es) Composiciones de celecoxib.
GT200900056A (es) Benzoxazoles y oxazolopiridinas utiles como inhibidores de la quinasa janus
BR112012023324B8 (pt) processo de preparação de uma forma de dosagem multifásica liofilizada de dissolução rápida
AR054782A2 (es) Composiciones farmaceuticas y tabletas que contienen irbesartan en combinacion con un diuretico
CL2009000860A1 (es) Compuestos derivados de 4-fenil-4-metil-5,6-dihidro-4h-1,3-tiazina-2-amina; composiciones farmaceuticas que los contienen; y uso de los compuestos en la preparacion de medicamentos inhibidores de bace, utiles para el tratamiento de trastornos mediados por esta enzima, tal como la enfermedad de alzheimer.
PE20091184A1 (es) Formas de dosificacion farmaceutica
PE20061016A1 (es) Una formulacion solida de dosificacion farmaceutica
NO20073059L (no) 2,3,4,9-tetrahydro-1h-carbazole derivatives as crth2 receptor antagonists
NZ595127A (en) Stable pharmaceutical composition for atherosclerosis
MX2011011459A (es) Formulacion de clavulanato para neuroproteccion y tratamiento de trastornos neurodegenerativos.
MY209656A (en) Compositions and methods of enhancing 5-hydroxytryptophan bioavailability
MX2019015733A (es) Formulacion de melatonina oralmente disoluble con agente acidificante que produce melatonina soluble en saliva.
WO2008039351A3 (en) Method of manufacturing tablets containing pharmacologically active agents
UA92011C2 (ru) Облатка, содержащая стероидные гормоны
BRPI0821454B8 (pt) formulação farmacêutica, mistura de glicogênio, alginato e sais de metais alcalino terrosos, processos para a produção de um excipiente de liberação lenta, e de uma forma farmacêutica
Jadhav et al. Effect of 3 types of antifungal agents on hardness of 2 different commercially available tissue conditioners: An: in-vitro: study
BRPI0700133A (pt) composição farmacêutica compreendendo tramadol e cetoprofeno em combinação

Legal Events

Date Code Title Description
B25D Requested change of name of applicant approved

Owner name: VELOXIS PHARMACEUTICALS A/S (DK)

B08F Application fees: application dismissed [chapter 8.6 patent gazette]

Free format text: REFERENTE A 9A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2261 DE 06/05/2014.